Sofosbuvir
Showing 26 - 50 of 431
Kidney Failure, Chronic, Hepatitis C Trial in Lucknow (Sofosbuvir, Daclatasvir 60 mg)
Completed
- Kidney Failure, Chronic
- Hepatitis C
- Sofosbuvir
- Daclatasvir 60 mg
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Apr 4, 2021
Hepatitis C Trial in Alor Star (Sofosbuvir 400 MG, Ravidasvir 200mg)
Recruiting
- Hepatitis C
- Sofosbuvir 400 MG
- Ravidasvir 200mg
-
Alor Star, Kedah, MalaysiaHospital Sultanah Bahiyah
May 17, 2021
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Hepatitis C and HIV Coinfection Trial in Aurora (Blood draws for tenofovir PK, renal function)
Completed
- Hepatitis C and HIV Coinfection
- Blood draws for tenofovir PK, renal function
-
Aurora, ColoradoUniversity of Colorado Hospital
Aug 10, 2021
Covid19 Trial in Alexandria (Sofosbuvir 400 MG/ Daclatasvir 60mg)
Completed
- Covid19
- Sofosbuvir 400 MG/ Daclatasvir 60mg
-
Alexandria, EgyptAmr Aly Abd elmoety
Feb 25, 2021
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))
Recruiting
- Hepatitis C
- +2 more
- Sofosbuvir/velpatasvir (Epclusa®)
-
Hazard, KentuckyARH Medical Mall
Sep 25, 2022
Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)
Completed
- Hepatitis C Virus Infection
-
Seongnam-si, Gyeonggi-D, Korea, Republic of
- +21 more
Sep 29, 2021
Hepatitis C, Chronic Hepatitis Trial in Melbourne, Barcelona (Daclatasvir, Sofosbuvir)
Terminated
- Hepatitis C
- Chronic Hepatitis
- Daclatasvir
- Sofosbuvir
-
Melbourne, Victoria, Australia
- +1 more
Apr 16, 2021
COVID Trial in Tanta (sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir)
Recruiting
- COVID
- sofosbuvir
- +2 more
-
Tanta, EgyptSherief Abd-Elsalam
Dec 3, 2020
Chronic Hepatitis C Trial in Cairo (Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir /
Recruiting
- Chronic Hepatitis C
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
- Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
-
Cairo, EgyptFaculty of medicine Helwan University
Jan 3, 2021
Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)
Completed
- Chronic Hepatitis C
-
Baltimore, MarylandInstitute of Human Virology University of Maryland
Apr 26, 2021
Covid19 Trial in Tanta (Sofosbuvir, Daclatasvir)
Unknown status
- Covid19
- Sofosbuvir
- Daclatasvir
-
Tanta, EgyptCairo and Tanta Universitities
Dec 2, 2020
Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus
Recruiting
- Hepatitis C Virus Infection
- +3 more
- Vosevi 400/100/100 Oral Tablet
-
Beigang, Taiwan
- +14 more
Oct 25, 2021
Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)
Active, not recruiting
- Hepatocellular Carcinoma
- +3 more
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Jan 14, 2022
HCV Trial in Bonn, 's-Hertogenbosch, Nijmegen (sofosbuvir/velpatasvir tablet, sofosbuvir/velpatasvir crushed)
Withdrawn
- HCV
- sofosbuvir/velpatasvir tablet
- sofosbuvir/velpatasvir crushed
-
Bonn, Germany
- +2 more
Dec 4, 2020
Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick
Recruiting
- Hepatitis C
- OraQuick HCV Antibody test (OraSure Technologies, Inc)
- +2 more
-
Clayton South, Victoria, Australia
- +5 more
Aug 16, 2022
Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir
Completed
- Chronic Hepatitis C Infection
- +2 more
- Ledipasvir/Sofosbuvir
- +4 more
-
Hong Kong, Hong Kong, ChinaHumanity and Health GI and Liver Centre
Aug 27, 2021
Hepatitis C, Acute Hepatitis C Trial in Germany (Sofosbuvir and Velpatasvir)
Completed
- Hepatitis C
- Acute Hepatitis C
- Sofosbuvir and Velpatasvir
-
Berlin-Friedrichshain, Germany
- +13 more
Jul 2, 2021
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir
Terminated
- Hepatitis C Virus Infection
- Sofosbuvir (SOF)
- +3 more
-
Phoenix, Arizona
- +50 more
Jan 25, 2023
Healthy Trial in Changsha (ASC18, ravidasvir and sofosbuvir)
Completed
- Healthy
- ASC18
- ravidasvir and sofosbuvir
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Jan 7, 2021
Hepatitis C, Lung Transplant Trial in Pittsburgh (Epclusa)
Active, not recruiting
- Hepatitis C
- Lung Transplant
-
Pittsburgh, PennsylvaniaUPMC
Oct 4, 2021
Hepatitis C, Drug Use, Viral Hepatitis C Trial in Hai Phong, H?i Phòng (Sofosbuvir 400 mg and Daclatasvir 60 mg, Sofosbuvir 400
Completed
- Hepatitis C
- +2 more
- Sofosbuvir 400 mg and Daclatasvir 60 mg
- +3 more
-
Hai Phong, Vietnam
- +1 more
Jan 28, 2021
Covid19 Trial in Cairo (Sofosbuvir plus Ledipasvir)
Completed
- Covid19
- Sofosbuvir plus Ledipasvir
-
Cairo, EgyptAlmaza Military Fever Hospital
Aug 27, 2020